https://www.selleckchem.com/pr....oducts/rg2833-rgfp10
Immune-checkpoint inhibitors are effective in many advanced tumors. However, there is scarce information regarding the radiological response to these agents in hepatocellular carcinoma outside clinical trials. We aimed to describe the radiological response in a retrospective cohort of hepatocellular carcinoma patients treated with nivolumab and to analyze the radiological evolution according to tumor response at first post-treatment radiological assessment. We reviewed pre-treatment and post-treatment images (CT or MRI) obtained
Like
Comment
Share
